Table 1: Clinical Trials of AmplimexonŽ
Protocol No. |
Phase |
Combination with |
Target |
Status |
Results |
AMP-001 |
I |
None |
Metastatic Cancer |
Completed |
Response In Lymphoma |
AMP-011 |
I |
None |
Metastatic Cancer |
Completed |
MTD Established |
AMP-007 |
I |
None |
Multiple Myeloma |
Completed |
No Responses |
AMP-005 |
I/II |
DTIC |
Malignant Melanoma |
Completed |
Prolonged Survival |
AMP-004 |
I |
Gemzar |
Pancreatic Cancer |
Completed |
Responses Noted |
AMP-010 |
I |
Taxotere |
Lung, Breast, Prostate Cancer |
Completed |
Responses In Lung and Prostate |
AMP-019 |
II |
Gemzar |
Pancreatic Cancer |
Ongoing |
Survival Endpoint early 2010 |
AMP-024 |
II |
Taxotere |
Lung Cancer |
Planned |
- |
AMP-008 |
II |
DTIC |
Malignant Melanoma |
Planned |
- |